CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | SING GEORGE L Director | Sale | −500 | $995.00 | $498K | 26,349 |
| 2024-02-26 | SING GEORGE L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −1,000 | 5,338 | ||
| 2024-02-26 | STAHL NEIL EVP Research and Development | Gift | −1,020 | 50,999 | ||
| 2024-02-26 | Bassler Bonnie L Director | Option exercise | +854 | $391.92 | $335K | 2,236 |
| 2024-02-26 | Bassler Bonnie L Director | Sale | −854 | $979.25 | $836K | 1,382 |
| 2024-02-26 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −854 | 0 | ||
| 2024-02-23 | SING GEORGE L Director | Option exercise | +500 | $413.33 | $207K | 26,849 |
| 2024-02-23 | SING GEORGE L Director | Sale | −500 | $985.00 | $493K | 26,349 |
| 2024-02-23 | SING GEORGE L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −500 | 6,338 | ||
| 2024-02-22 | LAROSA JOSEPH J EVP General Counsel and Secret | Sale | −1,000 | $967.65 | $968K | 37,543 |
| 2024-02-22 | SING GEORGE L Director | Option exercise | +1,000 | $413.33 | $413K | 27,349 |
| 2024-02-22 | SING GEORGE L Director | Sale | −1,000 | $970.00 | $970K | 26,349 |
| 2024-02-22 | SING GEORGE L Director | Option exercise | +1,000 | $413.33 | $413K | 27,349 |
| 2024-02-22 | SING GEORGE L Director | Sale | −1,000 | $965.00 | $965K | 26,349 |
| 2024-02-22 | SING GEORGE L Director | Option exercise | +1,000 | $413.33 | $413K | 27,349 |
| 2024-02-22 | SING GEORGE L Director | Sale | −1,000 | $960.00 | $960K | 26,349 |
| 2024-02-22 | SING GEORGE L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,000 | 6,838 | ||
| 2024-02-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Option exercise | +172,723 | $399.66 | $69.0M | 925,209 |
| 2024-02-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Shares withheld for taxes | −123,601 | $953.83 | $117.9M | 801,608 |
| 2024-02-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Option exercise · Non-Qualified Stock Option (right to buy) | −172,723 | 0 |
Page 34 of 49 · 971 trades